(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Term ID

CHEBI:150221

Synonyms

alpha-D-gluco-hexopyranosyl-(1->6)-alpha-D-gluco-hexopyranosyl-(1->6)-alpha-D-gluco-hexofuranose
Glc(a1-6)Glc(a1-6)a-Glcf
WURCS=2.0/2,3,2/[a2122h-1a_1-4][a2122h-1a_1-5]/1-2-2/a6-b1_b6-c1

Definition

References

GlyGen:G35061TT
GlyTouCan:G35061TT

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycoside

glycoside Show first 5 Terms

Phenotype

Phenotype resulting from (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype where environments contain (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Human Disease Model